Sinaptica begins Phase II dual neurostimulation Alzheimer’s study enrolment
Sinaptica Therapeutics has begun enrolling patients in a Phase II trial of its second-generation neuromodulation technology for treating early Alzheimer’s. The post Sinaptica begins Phase II dual neurostimulation Alzheimer’s study enrolment appeared first on Medical Device Network.
Sinaptica Therapeutics has begun enrolling patients in a Phase II trial of its second-generation neuromodulation technology for treating early Alzheimer’s.
The post Sinaptica begins Phase II dual neurostimulation Alzheimer’s study enrolment appeared first on Medical Device Network.
